Captain Blogs

Cardinal Health is in the Health Care sector and Health Care Providers & Services industry. The next Cardinal Health (CAH) dividend date is projected to be Monday, October 2, 2023. Highlights important summary options statistics to provide a forward looking indication of investors’ sentiment.

In the fourth quarter of fiscal 2023, pharmaceutical revenues totaled $49.7 billion, up 15% on a year-over-year basis. The performance highlights branded pharmaceutical sales growth from existing Pharmaceutical Distribution and Specialty Solutions customers. The Barchart Technical Opinion widget shows you today’s overally Barchart Opinion with general information on how to interpret the short and longer term signals.

A stock’s beta measures how closely tied its price movements have been to the performance of the overall market. Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated. © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

• In an exclusive interview, Wood expressed satisfaction with DraftKings’ performance over the past years, highlighting its diversification into areas like non-fungible tokens and its strong position alongside FanDuel.
• Although there is an improving trend for costs and expenses, these are likely to hurt margins in fiscal 2024, especially in the first half.
• Sprecher notes that ICE can feed info of a home’s details into the Ellie Mae algorithm to calculate its real-time value, showing the mortgage holder whether the price has gone up or down, and where it stands right now.
• There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score.

Provides a general description of the business conducted by this company. CAH earnings call for the period ending September 30, 2021. If the tide runs out, you won’t be caught swimming naked with these two stocks in your portfolio.

Cardinal’s a Critical Link in the Pharma Supply Chain

The deal will give Cardinal Health a minority stake in the combined entity, … CAH, -1.27% on Thursday said it authorized a new $3.5 billion stock buyback program until the end of 2027. Cardinal Health said it expects 2024 adjusted profit of $6.45 to $6.70 a… ORLANDO, Fla.–(BUSINESS WIRE)–Transaction Data Systems (TDS), a portfolio company of BlackRock Long Term Private Capital and GTCR, is pleased to announce the closing of the previously announced tran…

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.32% per year. These returns cover a period from January 1, 1988 through July 31, 2023.

They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends. Cardinal Health is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With roughly $190 billion in annual U.S. drug distribution sales in fiscal year 2023, the company supplies roughly a quarter of the overall market. Together, the three operate as a pharmaceutical wholesale and distribution oligopoly, supplying over 90% of the U.S. market.

Research & Ratings Cardinal Health Inc.(CAH)

Compare
CAH’s historical performance
against its industry peers and the overall market. Cardinal Health’s stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (11.21%), State Street Corp (5.93%), Geode Capital Management LLC (2.13%), Acadian Asset Management LLC (1.39%), Northern Trust Corp (1.30%) and Pacer Advisors Inc. (1.19%). Insiders that own company stock include Deborah Weitzman, Jessica L Mayer, Mary C Scherer, Michelle Brennan, Ola M Snow and Stephen M Mason.

Strong demand across product categories, brand, specialty, consumer health and generics drove the top line for Cardinal Health’s Pharma segment in the last reported quarter. GLP-1 medications were an increasing contributor https://1investing.in/ to the top line in the last couple of quarters that is likely to rise significantly going forward. Shares of this Zacks Rank #3 (Hold) company have risen 15.5% year to date compared with the industry’s 12% growth.

Morningstar Runs the Numbers

Vlad Tenev, Robinhood’s CEO, expressed optimism about the company’s future, emphasizing its commitment to innovation and growth. Indeed, Sprecher notes that today, ICE is handling around 10% of all end-to-end home loan production on its digital platform. “That’s an increase from virtually zero mortgages handled electronically a few years ago,” he adds. He believes that once the Black Knight platform is fully integrated, ICE will be able to substantially reduce today’s typical cost of $8,000 or more, and cut the time from origination to closing to as little as a few days. Cardinal Health saw a increase in short interest in August. As of August 31st, there was short interest totaling 10,680,000 shares, an increase of 107.0% from the August 15th total of 5,160,000 shares.

Data may be intentionally delayed pursuant to supplier requirements. In an exclusive interview, Wood expressed satisfaction with DraftKings’ performance over the past years, highlighting its diversification into areas like non-fungible tokens and its strong position alongside FanDuel. Our experts picked 7 Zacks Rank #1 Strong Buy stocks with the best chance to skyrocket within the next days. Some better-ranked stocks in the broader medical space are Align Technology (ALGN Quick QuoteALGN – Free Report) , HealthEquity, Inc. (HQY Quick QuoteHQY – Free Report) and McKesson Corporation (MCK Quick QuoteMCK – Free Report) . Cardinal Health Inc. (CAH Quick QuoteCAH – Free Report) is well poised for growth, given its acquisition-driven strategy, a diversified product portfolio and a robust pharmaceutical segment.

About Cardinal Health (NYSE:CAH) Stock

Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Along with Cencora and McKesson, the three comprise well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia. High-growth stocks tend to represent the technology, healthcare, and communications sectors.

In April, Cardinal Health opened a new distribution center in Ohio to focus on its U.S. Medical Products and Distribution, and at-Home Solutions businesses. Meanwhile, the return of international freight to pre-pandemic levels implies normalization of freight costs going forward, benefiting CAH’s bottom line in fiscal 2024. Moreover, strong CapEx plans for continued investments in new product development and capacity expansion, and divesture of non-healthcare portfolio buoy optimism.

Revenue increased 13% to $50.5 billion GAAP1 operating earnings were $572 million; GAAP diluted EPS was $1.34 Non-GAAP operating earnings increased 11% to $606 million; non-GAAP diluted EPS increased … Cardinal Health, a manufacturer and distributor of medical and laboratory products, has teamed up with Square to provide payment solutions for independent pharmacies. New facility is the largest at-Home Solutions has built to date, set to accommodate continued business and home healthcare industry growth DUBLIN, Ohio , June 15, 2023 /PRNewswire/ — Cardinal Health … Data are provided ‘as is’ for informational purposes only and are not intended for trading purposes.

Many investors continue to look for growth wherever they can find it. It’s interesting that Sprecher seeks to restore the bonds of loyalty functions of channel of distribution homeowners once felt for their neighborhood banks. If it works, it’ll lower costs for consumers—and mean big profits for ICE.

Empowering Infant Care: Cardinal Health Unveils NTrainer System 2.0 To Enhance Neonatal Feeding

Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. After each calculation the program assigns a Buy, Sell, or Hold value with the study, depending on where the price lies in reference to the common interpretation of the study.

In August, Cardinal Health launched its next-generation NTrainer System 2.0. The medical device is expected to help in reducing the neonatal intensive care unit (NICU) length of stay for premature and newborn infants. Société Générale’s top U.S. equity strategist has lifted his S&P 500 target for 2023, saying investors want to buy growth and industrials.

During the fiscal fourth quarter, CAH launched its Navista Network — a specific suite of offering for community oncologists. Moreover, the company merges its Outcomes service with BlackRock’s transaction data system, creating opportunity for pharmacies’ growth. The Medical segment’s sales are being primarily driven by robust demand for at-home solutions as well as an improvement in pricing for products. Moreover, cost optimizing measures have helped the company improve margins for the segment during the last reported quarter. Cardinal Health expects to resolve the impact of inflationary pressures and global supply-chain constraint by the end of fiscal 2024, paving a path for strong recovery in margins going forward. The company’s focus on promoting Cardinal Health brand volumewith a 5-point plan is likely to boost its prospect this financial year.